Corneal specimens obtained during surgery from patients with macular corneal dystrophy and obtained at autopsy from control eyes were incubated in a medium containing radioactive precursors of glycoproteins and proteoglycans. Biosyntheticallyradiolabeled material was extracted and characterized by using molecular sieve chromatography and specific enzymes. Cells in control corneas synthesized both a chondroitin sulfate proteoglycan and a keratan sulfate proteoglycan similar to those present in monkey and bovine corneas. Cells in macular corneas synthesized a normal chondroitin sulfate proteoglycan but did not synthesize either keratan sulfate or a mature keratan sulfate proteoglycan. Instead, macular corneas synthesized a glycoprotein with unusually large oligosaccharide side chains. This glycoprotein was not detected in normal corneas and is slightly smaller than normal keratan sulfate prot can. The failure to synthesize a mature keratan sulfate proteoglycan may produce corneal opacity and result in blindness. Because of evidence indicating that the corneal keratan sulfate proteoglycan is normally synthesized through a glycoprotein intermediate [Hart, G. W. & Lennarz, W. (1978) J. Biol. Chem. 253,5795-5801, macular corneal dystrophy may be a defect in glycoprotein processing. Macular, lattice, and granular corneal dystrophies are characterized by specific abnormalities of the corneal stroma and result in loss of vision (1). Macular corneal dystrophy is characterized clinically by recessive inheritance, a general diffuse haze throughout the corneal stroma, and the accumulation of irregularly shaped deposits which tend to be anterior in the central region of the stroma. Histologically, the deposits are primarily extracellular and stain positively with Alcian blue and the periodic acid-Schiff reagent (2, 3). These observations suggest that the deposits may be glycosaminoglycans and oligosaccharides accumulating in the stromal extracellular matrix.
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The extracellular matrix of the normal corneal stroma consists primarily of type I collagen and two proteoglycans: a chondroitin-dermatan sulfate proteoglycan and a keratan sulfate proteoglycan (4) (5) (6) (7) (8) (9) . Because most of the sulfated carbohydrate in the cornea is contained in these two proteoglycans, macular corneal dystrophy may involve alterations in one or both of these proteoglycans. Recently, an organ culture system utilizing monkey corneas has been developed that allows the biosynthesis of radiolabeled corneal stromal proteoglycans in vItro (9) . This system involves incubating intact corneas in a tissue culture medium containing radioactive precursors. Analyses of the radiolabeled proteoglycans synthesized during organ culture indicated that they were representative of the proteoglycans that accumulate in the stromal extracellular matrix.
The corneal cloudiness in individuals with macular corneal (10) . Therefore, the organ culture system appeared to be a promising technique for studying the proteoglycans of macular corneas obtained from keratoplasty.
The data presented here suggest that the cloudiness in corneas from patients with macular corneal dystrophy results from the failure to synthesize a mature keratan sulfate proteoglycan.
MATERIALS AND METHODS Organ Culture Procedures. Corneas excised with a 7-to 8-mm trephine blade were obtained from human eyes at keratoplasty or from control donor eyes at autopsy. Corneas obtained at surgery included three from two patients with macular dystrophy (here termed "macular corneas"), one from a patient with lattice dystrophy, two from two patients with granular dystrophy, one from a patient with keratoconus, and two from normal donor eyes (here termed "control corneas"). Specimens were placed immediately in Eagle's minimal essential medium supplemented with 5% fetal calf serum, 2 mM glutamine, and 100 units of penicillin and 50 ,ug of streptomycin per ml. The medium also contained 200-400 ,Ci of [6-3H] glucosamine per ml and 1.0-1.5 mCi of Na235SO4 per ml (New England Nuclear; 1 Ci = 3.7 X 1010 becquerels). The corneas were incubated at 370C for [18] [19] [20] hr in 5% C02/95% air at 100% humidity. At the end of the incubation period the corneas were rinsed briefly in phosphate-buffered saline and stored frozen at -700C.
Biochemical Procedures. Each cornea was individually thawed, the epithelium and endothelium were removed rapidly by scraping, and the stroma was placed in 1.0 ml of extraction solvent containing 4 M guanidine-HCL 0.1 M 6-aminohexanoic acid, 0.01 M Na2 EDTA, 5 mM benzamidine hydrochloride, and 0.5 M sodium acetate (pH 5.8-6.0) for 24 hr at 4°C (11) . The extracting solvent was removed, and the stroma was reextracted in 0.5 ml of the same solvent for 4-6 hr at 40C. The extracts were combined, and unincorporated radioactivity was removed by chromatography on a Sephadex G-25 PD-10 column (Pharmacia) that had been equilibrated with and eluted with 4 M guanidine-HCI/0.02 M Tris-HCI, pH 7 .0. The residual tissue was digested with 0.5 mg papain (Sigma) in 1.0 ml of 1 M sodium acetate, pH 6.5/5 mM cysteine/5 mM EDTA at 55-i60C for 6 hr. Any unincorporated radioactivity in the digest was removed by chromatography on PD-10 columns as described above.
The glycoconjugates in the 4 M guanidine.HCI extract were fractionated on a Sepharose CL-4B column (200 X 1.6 cm; 4.2 ml collected per tube), equilibrated, and eluted with 4 M gua-nidine-HCI/0.02 M Tris, pH 7.0. The radioactively labeled peak fractions were pooled, dialyzed against distilled water, and lyophilized. These peak fractions were then dissolved in 4 M guanidine-HCI/0.02 M Tris, pH 7.0, and divided into two parts. One part was directly applied to a Sepharose CL-6B column (90 X 1.5 cm, 2.0 ml collected per tube), equilibrated, and eluted with 4 M guanidine.HCl/0.02 M Tris.HCl, pH 7.0. The second part was digested with papain and fractionated on Sepharose CL-6B as described to isolate the glycosaminoglycans and glycopeptides. The tubes containing the peak fractions were pooled, dialyzed against distilled water, and lyophilized.
The glycosaminoglycans and glycopeptides isolated from Sepharose CL-6B were sequentially digested with chondroitinase ABC (Miles), keratanase (keratan sulfate-f3-endogalactosidase, a gift from Sakaru Suzuki), and nitrous acid as described (9, 12) . In brief, the samples were digested with chondroitinase ABC and chromatographed on Sephadex G-50 (0.6 X 30cm, 1.0 ml collected per tube). The amount digested was determined by the shift in elution position from a higher to a lower molecular weight. The undigested higher molecular weight material was then digested with the keratanase and the amount digested was determined again. Undigested samples eluted from the same column served as "blanks." Samples also were digested for 18 hr at 370C with 2 units of mixed exoglycosidases per ml (Miles) in 0.4 M sodium acetate buffer, pH 4.4/0.1 M NaCI.
Radioactivities in fractions were measured by liquid scintillation spectrophotometry with 10 ml of ACS (Amersham). Aliquots (0.01-0.2 ml) from each tube were assayed for radioactivity. An equivalent amount of 70% ethanol was added when measuring samples in 4 M guanidine.HG. An external standard was used to correct for spillover of M5S into the 3H channel. RESULTS There were two major differences between labeled macromolecules obtained from control and macular corneas incubated with [3H]glucoaaniine and [35Sisulfate. First, substantially less of the total incorporated 3H and [35S]sulfate in macular corneas was extracted by 4 M guanidine.HCl. Extracts of control corneas contained 81-88% (8148% for 3H and 8588% for MS) of the total incorporated radioactivity, whereas extracts of macular corneas contained only 55-60% (55-57% for 3H and 59-60% for35S) of the total incorporated radioactivity. Fractionation of the extract on Sepharose CL-4B revealed the second major difference between control and macular corneas (Fig. 1) . The extract of control corneas was fractionated into two peaks containing 3H and two peaks (labeled 2 and 3) containing both 3H and 35S (Fig. 1A) . The extract of the macular corneas also eluted as four peaks of radioactivity in approximately the same positions as the controls. However, peak 3 from macular corneas contained low levels of 35S and eluted later than peak 3 from control corneas (Fig. 1B) .
Peak 2 material isolated by elution from the Sepharose CL-4B column was chromatographed on Sepharose CL-6B (Fig. 2) . Intact peak 2 material from control corneas ( Fig. 2A) eluted as a single peak at tube 28. After papain digestion, peak 2 material produced two radiolabeled peaks on CL-6B (Fig. 2B ): a major glycosaminoglycan peak at tube 32 (designated peak 2a) containing both 3H and 35S and a minor peak at tube 53 containing only 3H. By comparing its elution position to positions of chondroitin sulfate chains of known molecular weight, the molecular weight of the glycosaminoglycan peak was estimated to be 55,000 (13) . The shift in the elution position of the 35S in the intact proteoglycan ( Fig. 2A) to a lower molecular weight after papain digestion (Fig. 2B) is evidence that protein is part of this material. Similar results were obtained by chromatography of intact (Fig. 2C) and degraded (Fig. 2D ) peak 2 material from macular corneas on Sepharose CL-6B.
Peak 3 material, isolated by Sepharose CL-4B chromatography, was chromatographed on Sepharose CL-6B. Intact peak 3 material from control corneas (Fig. 3A) eluted as a single peak at tube 30. After papain digestion, two radiolabeled peaks were observed ( Fig. 3B ): a glycosaminoglycan peak at tube 41 (designated peak 3b) with a preceding shoulder (designated peak 3a) containing both 3H and 35S and another peak at tube 50 containing only 3H. By comparing its elution position to positions of chondroitin sulfate chains of known molecular weight, the molecular weight of the major glycosaminoglycan peak was estimated to be 15,000 (13) . Intact peak 3 material from macular corneas was eluted as a single peak at tube 34 (Fig. 3C ), which indicated a slightly lower molecular weight than that of intact peak 3 material from control corneas (Fig.  3A) . Papain digestion prior to chromatography produced three radiolabeled peaks (Fig. 3D ) in elution positions similar to those obtained by digestion of control peak 3 material. There were, however, some major differences between the oligosaccharides of control and macular peak 3 materials. First, although the major 3H-labeled peak (peak 3b) also contained a5S in the control (Fig. 3B) , it contained only the 3H in the macular material (Fig. 3D) . Furthermore, peak 3b from macular corneas eluted at tube 44, which indicates that the oligosaccharides in peak 3b of macular corneas are lower in molecular weight (t 10,000) than the glycosaminoglycan in peak 3b of control corneas. The peak 3a material in both control and macular corneas are glycosoaminoglycans derived from peak 2 proteoglycans that contaminate peak 3.
The oligosaccharides in peaks 2a and 3b were subjected to treatments that degrade certain types of glycosaminoglycans ( Fig. 1. (A) Intact peak 2 material from control corieas; (B) papaintreated peak 2 material from control corneas; (C) intact peak 2 material from macular corneas; (D) papain-treated peak 2 material from macular corneas. Brackets denote pooled tubes. macular corneas. The majority of the peak Sb material from control corneas was digested by keratanase, indicating that peak 3 material contained the keratan sulfate proteoglycan. However, peak 3 material from macular corneas was resistant to keratanase as well as chondroitinase and nitrous acid. Keratanase degrades an unsulfated keratan sulfate (Sakaru Suzuki, personal communication).
Peak 3b materials from control and macular corneas were also digested with a mixture of exoglycosidases, and the digests were chromatographed on Sephadex G-50 (Fig. 4) . The results showed that peak Sb material from macular corneas was sensitive to this mixture of enzymes (Fig. 4B ) but peak Sb material from control corneas was resistant (Fig. 4A) . Because this mixture contains enzymes that attack specific glycosidic linkages found only in the oligosaccharide portion of glycoproteins, it appears that the oligosaccharide in peak 3b from macular corneas is derived from a glycoprotein.
The material not extracted from the stroma by 4 M guanidine-HCI (residue) was digested with papain and fractionated on Sepharose CL-6B (Fig. 5) . Four peaks of radiolabeled material were obtained from the residue of control corneas, with the majority of the 3H eluted as a low molecular weight peak at tube 50 (Fig. 5A) . Peaks R-b and R-c correspond in elution position to the chondroitin sulfate glycosaminoglycan side chain and the keratan sulfate side chain, respectively (see Fig. 2, Fig.  3 , and Table 1 ). Only three peaks of radiolabeled material were obtained from the residue of macular corneas, with the majority of the 3H eluted in peak R-b (Fig. 5B) . Peak R-c was absent. Greater than 95% of the 3H in peak R-b of both control and macular samples was sensitive to chondroitinase ABC. These observations indicate that the proteoglycans not extracted by 4 M guanidine.HCl in both the control and the macular samples contain glycosaminoglycans that resemble the glycosaminoglycans of the proteoglycans extracted from those tissues. Furthermore, the reduced extractability of incorporated radiolabel in macular corneas noted previously can be attributed to radioactivity in chondroitin sulfate remaining in the residue and not keratan sulfate. Thus, our analyses confirmed previous work that also could not detect labeled keratan sulfate in macular corneas radiolabeled in an organ culture system different from that used in this study (14) .
The proteoglycan data for granular, lattice, and keratoconus corneas were indistinguishable from that found for control corneas (not shown). The lattice, granular, and keratoconus corneas are more appropriate controls than normal corneas because the patients were subjected to the same preoperative procedures as the patients with macular dystrophy. Moreover, it indicates that not all corneal dystrophies that involve stromal extracellular matrix abnormalities also involve changes in stromal proteoglycans. droitin sulfate proteoglycan contains one or two chondroitin sulfate side chains with a molecular weight of --55,000 attached to a protein core to produce a macromolecule with a molecular weight of t150,000. The keratan sulfate proteoglycan consists of 2 to 3 keratan sulfate side chains with a molecular weight of -10,000 attached to a protein core, forming an intact proteoglycan with a molecular weight of -75,000. The results of the present study indicate that stromacytes in normal human corneas synthesize proteoglycans in organ culture similar to those previously found in monkey and bovine corneas.
Corneas from patients with macular corneal dystrophy synthesize an apparently normal chondroitin sulfate proteoglycan, although it is not as extractable as the chondroitin sulfate proteoglycan from control corneas. Corneal macular dystrophy is distinctly different from the diseases termed "mucopolysaccharidoses" (26) (27) (28) . For example, light and electron microscopic studies have showed that, in addition to the accumulations of deposits in the stromal extracellular matrix, the endoplasmic reticulum of the corneal stromacytes also contain accumulations of similar material (28, 29) . Since 
